Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00900263
First received: May 9, 2009
Last updated: October 6, 2016
Last verified: October 2016